Mihael H. Polymeropoulos, MD, cofounded Vanda and has served as President, Chief Executive Officer and Chairman of the Board since June 2021, and as President, Chief Executive Officer and Director from May 2003 to June 2021. From 1998 to 2003, Dr. Polymeropoulos was Vice President and Head of the Pharmacogenetics Department at Novartis AG. Prior to Novartis, he served as Chief of the Gene Mapping Section, Laboratory of Genetic Disease Research, National Human Genome Research Institute, from 1992 to 1998. Dr. Polymeropoulos is the cofounder of the Integrated Molecular Analysis of Genome Expression (I.M.A.G.E.) Consortium. Dr. Polymeropoulos holds a degree in Medicine from the University of Patras.